Dalekos G et al. Efficacy of GKT831 in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid: Interim efficacy results of a phase 2 clinical trial. (Abstract GS-02)
Koorts meest gerapporteerd bij vaccinaties kinderen t/m 14 maanden
mei 2026 | Vaccinatie